Provided by Tiger Fintech (Singapore) Pte. Ltd.

Syndax Pharmaceuticals

10.25
-0.4200-3.94%
Post-market: 10.250.00000.00%16:31 EDT
Volume:1.31M
Turnover:13.45M
Market Cap:881.99M
PE:-2.66
High:10.58
Open:10.44
Low:10.05
Close:10.67
Loading ...

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
05 Apr

Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum

GlobeNewswire
·
02 Apr

Syndax Pharmaceuticals Is Maintained at Overweight by JP Morgan

Dow Jones
·
20 Mar

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
06 Mar

Syndax Pharmaceuticals Inc (SNDX) Q4 2024 Earnings Call Highlights: Strong Product Launch and ...

GuruFocus.com
·
05 Mar

Positive Outlook on Syndax Pharmaceuticals: Strong Market Presence and Strategic Growth Initiatives

TIPRANKS
·
05 Mar

Stock Track | Syndax Pharmaceuticals Plunges 8.91% Amid Disclosed Risks to Revenue Growth

Stock Track
·
05 Mar

Syndax Pharmaceuticals Is Maintained at Buy by Citigroup

Dow Jones
·
05 Mar

B. Riley Cuts Price Target on Syndax Pharmaceuticals to $29 From $36, Keeps Buy Rating

MT Newswires Live
·
04 Mar

Scotiabank Remains a Hold on Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
04 Mar

Syndax Pharmaceuticals Price Target Maintained With a $51.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Mar

Syndax Pharmaceuticals Inc : Citigroup Cuts Target Price to $42 From $45

THOMSON REUTERS
·
04 Mar

Barclays Reaffirms Their Buy Rating on Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
04 Mar

Stock Track | Syndax Pharmaceuticals Plunges 8.27% in Pre-Market Amid Revenue Growth Challenges

Stock Track
·
04 Mar

Syndax Pharmaceuticals: Navigating Revenue Growth Amidst Regulatory and Market Challenges

TIPRANKS
·
04 Mar

Syndax Pharmaceuticals Reports 2024 Financial Results

TIPRANKS
·
04 Mar

BUZZ-Syndax Pharmaceuticals drops on wider quarterly loss

Reuters
·
04 Mar

Syndax Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
03 Mar

Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
03 Mar

Syndax Pharmaceuticals Q4 Loss Widens

MT Newswires Live
·
03 Mar